BDO has provided buy-side M&A, financial due diligence and tax advice to Prime Global in connection with its acquisition of HCD Economics.
Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies to deliver integrated evidence-led services.
BDO previously advised Prime Global in connection with Levine Leichtman Capital Partners' investment in the company in April 2021, and on the acquisition of Cambridge Medical Communication, now known as Cambridge, in 2020.
"HCD Economics and Prime Global are both focused on improving patients’ lives. Combining HCD’s evidence generation and analytic expertise with our specialist medical, patient, and payer communications skills will strengthen our support to clients, helping ensure patients have timely access to innovative treatments. I am excited to see the synergies we will create as our new partnership unfolds.
We are delighted to continue working with the fantastic team at BDO. They provided great support across this transaction, and continue to be a trusted partner and advisor to Prime Global as we execute our ambitious growth plans."
Graeme Peterson, Founder and Chief Executive Officer, Prime Global
“HCD Economics is highly complementary to Prime Global’s market access and health economics segment, which is a key strategic growth area for the business. We look forward to the benefits of this combination and to the continued execution of Prime Global’s ambitious growth plans through further M&A, both in Europe and the U.S. Additionally, we would like to thank the BDO team for their outstanding support across the entire spectrum of the deal process — they were instrumental in the successful completion of the transaction.”
Josh Kaufman, Senior Managing Director, Levine Leichtman Capital Partners